Phase 2CompletedAge-related condition

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs (Neu I)

Phase II Study of Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs.

Sponsor
Neurim Pharmaceuticals Ltd. (Industry)
Enrollment
40 enrolled
Conditions
Primary Insomnia
Interventions
placebo Circadin; Circadin
Ages
adults, older adults
Registry
NCT00816673

Full record on ClinicalTrials.gov

From the registry

The aim of this placebo controlled study is to investigate the effect of 2 mg melatonin Slow Release (Circadin®) on the sleep/wake cycle in elderly insomniac out-subjects, aged 55 years or more.

History

  1. Last registry update

  2. Registered

  3. Study completion

  4. Primary completion

  5. Started